Cited by 1,452COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

Open access
Du, Rong-Hui, Liang, Li-Rong, Yang, Cheng-Qing, Wang, Wen, Cao, Tan-Ze, Li, Ming, Guo, Guang-Yun, Du, Juan +6 more·2020·European Respiratory Journal

Abstract

The aim of this study was to identify factors associated with the death of patients with COVID-19 pneumonia caused by the novel coronavirus SARS-CoV-2. All clinical and laboratory parameters were collected prospectively from a cohort of patients with COVID-19 pneumonia who were hospitalised to Wuhan Pulmonary Hospital (Wuhan City, Hubei Province, China) between 25 December 2019 and 7 February 2020. Univariate and multivariate logistic regression was performed to investigate the relationship between each variable and the risk of death of COVID-19 pneumonia patients. In total, 179 patients with COVID-19 pneumonia (97 male and 82 female) were included in the present prospective study, of whom 21 died. Univariate and multivariate logistic regression analysis revealed that age ≥65 years (OR 3.765, 95% CI 1.201‒11.803; p=0.023), pre-existing concurrent cardiovascular or cerebrovascular diseases (OR 2.464, 95% CI 1.279‒4.747; p=0.007), CD3+CD8+T-cells ≤75 cells·μL−1(OR 3.982, 95% CI 1.761‒9.004; p<0.001) and cardiac troponin I ≥0.05 ng·mL−1(OR 4.077, 95% CI 1.778‒9.349; p<0.001) were associated with an increase in risk of mortality from COVID-19 pneumonia. In a sex-, age- and comorbid illness-matched case–control study, CD3+CD8+T-cells ≤75 cells·μL−1 and cardiac troponin I ≥0.05 ng·mL−1 remained as predictors for high mortality from COVID-19 pneumonia. We identified four risk factors: age ≥65 years, pre-existing concurrent cardiovascular or cerebrovascular diseases, CD3+CD8+T-cells ≤75 cells·μL−1 and cardiac troponin I ≥0.05 ng·mL−1. The latter two factors, especially, were predictors for mortality of COVID-19 pneumonia patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/13993003.00524-2020

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [22]National Health Commission of the People's Republic of China. Press conference of the State Council of the People's Republic of China. www.nhc.gov.cn/xcs/s3574/202002/5329d7ab7af24690a1d5b66982333af3.shtml. Date last accessed: 2 March 2020.

Cited by

Sorted by citations

Authors
Du, R.-H., Liang, L.-R., Yang, C.-Q., Wang, W., Cao, T.-Z., Li, M., Guo, G.-Y., Du, J., Zheng, C.-L., Zhu, Q., Hu, M., Li, X.-Y., Peng, P., & Shi, H.-Z.
Affiliations
  • Wuhan Pulmonary Hospital (CN)
  • Capital Medical University (CN)
Corresponding author
Shi, Huan-Zhong
Venue
European Respiratory Journal
Published
2020-04-08
Volume
55
Issue
5
Pages
2000524
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W3015552915
Cited by
1,452
References
18
Citations by year
2026: 8 · 2025: 26 · 2024: 78 · 2023: 112 · 2022: 236 · 2021: 495 · 2020: 495 · 2018: 1
FWCI
43.89
Type
journal article
Language
en
Open access
Locations
  • European Respiratory Journal (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • 1351 Talents Program of Beijing Chao-Yang Hospital, China (WXZXZ-2017-01)
  • Beijing Municipal Administration of Hospitals (SML20150301)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
Keywords
COVID-19 pneumonia, SARS-CoV-2, mortality risk factors, CD3+CD8+ T cells, cardiac troponin I, cardiovascular comorbidity, cerebrovascular disease, elderly patients, prognostic factors, hospitalized patients, case-control study, prospective cohort
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Age Factors, Aged, Aged, 80 and over, Cardiovascular Diseases, Cerebrovascular Disorders, China, Female, Humans, Male, Middle Aged, Pneumonia, Viral, Prospective Studies, Comorbidity, Case-Control Studies, Age Distribution, Coronavirus, Coronavirus Infections, CD8-Positive T-Lymphocytes, Troponin I, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review